<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Twenty-nine patients with <z:hpo ids='HP_0010783'>erythema</z:hpo> nodosum, nodular <z:hpo ids='HP_0002633'>vasculitis</z:hpo>, or <z:hpo ids='HP_0010783'>erythema</z:hpo> nodosum-like lesions associated with <z:chebi fb="6" ids="22696">Beh</z:chebi>çet's syndrome were treated with <z:chebi fb="0" ids="8346">potassium iodide</z:chebi> </plain></SENT>
<SENT sid="1" pm="."><plain>Administration of the drug for systemic effect showed a substantial effect in 11 of 15 patients with <z:hpo ids='HP_0010783'>erythema</z:hpo> nodosum, seven of ten with nodular <z:hpo ids='HP_0002633'>vasculitis</z:hpo>, and one of four with leg lesions of <z:chebi fb="6" ids="22696">Beh</z:chebi>çet's syndrome </plain></SENT>
<SENT sid="2" pm="."><plain>Relief of subjective symptoms, including tenderness, <z:hpo ids='HP_0002829'>joint pain</z:hpo>, and <z:hpo ids='HP_0001945'>fever</z:hpo>, occurred within 24 hours </plain></SENT>
<SENT sid="3" pm="."><plain>Substantial improvement in the eruption occurred within a few days, and the lesions disappeared completely ten to 14 days after therapy was initiated </plain></SENT>
<SENT sid="4" pm="."><plain>The patients to whom the medication was administered shortly after the initial <z:hpo ids='HP_0003674'>onset</z:hpo> of <z:hpo ids='HP_0010783'>erythema</z:hpo> nodosum seemed to respond most satisfactorily </plain></SENT>
<SENT sid="5" pm="."><plain>The effect of the drug was marked in the patients with positive C-reactive protein reactions, <z:hpo ids='HP_0002829'>joint pains</z:hpo>, and/or <z:hpo ids='HP_0001945'>fever</z:hpo> </plain></SENT>
<SENT sid="6" pm="."><plain>Possible mechanisms by which <z:chebi fb="0" ids="8346">potassium iodide</z:chebi> exerts its effect are discussed </plain></SENT>
</text></document>